Alqahtani, et al15a | Dhoble, et al4a | Thakkar, et al17a | ||||
---|---|---|---|---|---|---|
TAVR | SAVR | TAVR | SAVR | TAVR | SAVR | |
Characteristic | n=134 | n=134 | n=55 | n=55 | n=30 | n=30 |
Mean age, years | 71 | 71 | 67.2 | 67 | 71.7 | 70.5 |
Male | 84 (62.7) | 79 (59) | (65.5) | (65.5) | (73.3) | (66.7) |
Mean MELD score | NA | NA | NA | NA | NA | NA |
Chronic kidney disease | 52 (38.8) | 53 (39.6) | NA | NA | NA | NA |
Hypertension | 93 (69.4) | 93 (69.4) | NA | NA | (66.7) | (73.3) |
Diabetes | 64 (47.8) | 59 (44.0) | (58.2) | (54.4) | (53.3) | (53.3) |
Congestive heart failure | 17 (12.7) | 13 (9.7) | (56.4) | (54.5) | 0 | (13.3) |
Coronary artery disease | 55 (41.0) | 56 (41.8) | (61.8) | (43.6) | NA | NA |
Peripheral artery disease | 31 (23.1) | 28 (20.9) | (21.8) | (10.9) | (20.0) | (10.0) |
Atrial fibrillation or flutter | 54 (40.3) | 57 (42.5) | NA | NA | NA | NA |
Chronic lung disease | 38 (28.4) | 40 (29.9) | NA | NA | (23.3) | (43.3) |
↵aPatient numbers (n) not provided in the article for the characteristics.
Note: Data are presented as n (%) or as (%) unless otherwise indicated.
MELD, Model for End-Stage Liver Disease; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.